LENZ Therapeutics, Inc. Common Stock (LENZ) is a publicly traded Healthcare sector company. As of September 21, 2026, LENZ trades at $4.06 with a market cap of $127.88M and a P/E ratio of -1.43. LENZ moved -1.94% today. Year to date, LENZ is -74.56%; over the trailing twelve months it is -90.24%. Its 52-week range spans $4.01 to $50.40. Analyst consensus is buy with an average price target of $24.40. Rallies surfaces LENZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LENZ financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LENZ recently traded at $4.06. Market cap is $127.88M. P/E ratio is -1.43. Revenue is $19.09M.
| Metric | Value |
|---|---|
| Price | $4.06 |
| Market Cap | $127.88M |
| P/E Ratio | -1.43 |
| EPS | $-2.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.40 |
| 52-Week Low | $4.01 |
| Volume | 458.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $19.09M |
| Net Income | $-82.13M |
| Gross Margin | 97.81% |
6 analysts cover LENZ: 0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $24.40.